![]() |
市場調查報告書
商品編碼
2101883
2026-2035 年乳製品加工中超過濾和微過濾的市場機會、成長要素、產業趨勢和預測。Ultra-Filtration and Microfiltration in Dairy Processing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
全球乳製品加工用超過濾和微過濾市場預計到 2025 年將達到 19 億美元,年複合成長率為 9.4%,到 2035 年將達到 47 億美元。

這一成長是由多方面因素共同推動的:對高蛋白乳成分的需求不斷成長、食品加工環境中微生物安全標準日益嚴格,以及膜分離乳品生產系統的持續擴展。超過濾和微過濾技術正從輔助加工工具轉變為現代乳品生產的核心基礎設施,這得益於它們能夠提高蛋白質回收率、降低能耗(與熱蒸發相比)並提升整體製程效率。高蛋白乳成分的高溢價持續推動全部區域膜分離系統的再投資。同時,鑑於全球相當一部分人口患有不同程度的乳糖不耐症,對無乳糖乳製品的需求不斷成長,也推動了先進過濾製程的應用。膜分離系統能夠有效分離乳品,同時保留營養成分,從而支持全球乳品供應鏈的產品創新和合規性。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 19億美元 |
| 預測金額 | 47億美元 |
| 複合年成長率 | 9.4% |
累計到2025年,超過濾業務的銷售額將達到9.09億美元,佔市場佔有率的47.5%,到2035年將達到23億美元,年複合成長率為9.8%。該業務在乳製品加工行業中繼續發揮核心作用,膜系統被廣泛應用於主要產區的大規模乳製品加工廠,用於乳清蛋白濃縮、乳蛋白質濃縮物生產和預濃縮製程。
乳清加工市場規模達到6.08億美元,佔市場佔有率的31.7%,預計將以9.1%的複合年成長率成長,到2035年達到14.5億美元。這一市場主導地位歸功於薄膜過濾在乳清蛋白生產系統中的關鍵作用。這些系統透過超過濾,能夠以經濟高效的方式大規模生產高價值的濃縮蛋白和分離蛋白,滿足全球對富含蛋白質的乳製品原料的需求。
預計到2025年,北美乳製品加工領域的超過濾和微過濾市場規模將達到5.66億美元。美國仍然是主要的需求中心,這得益於其高度發達的乳清加工產業以及集中在主要乳製品產區的廣泛膜過濾基礎設施。先進分離技術在大規模乳製品加工廠的廣泛應用,進一步鞏固了主導地位。
The Global Ultra-Filtration and Microfiltration in Dairy Processing Market was valued at USD 1.9 billion in 2025 and is estimated to grow at a CAGR of 9.4% to reach USD 4.7 billion by 2035.

Growth is driven by the convergence of rising demand for high-protein dairy ingredients, stricter microbial safety requirements in food processing environments, and the continued scaling of membrane-based dairy manufacturing systems. Ultrafiltration and microfiltration technologies have shifted from secondary processing tools to core infrastructure in modern dairy production, supported by their ability to improve protein recovery, reduce energy consumption compared to thermal evaporation, and enhance overall process efficiency. Premium pricing for high-protein dairy ingredients continues to support reinvestment in membrane systems across major dairy-producing regions. At the same time, expanding demand for lactose-free dairy products is reinforcing the adoption of advanced filtration processes, as a significant share of the global population experiences varying degrees of lactose intolerance. Membrane-based separation systems enable efficient fractionation of dairy streams while preserving nutritional composition, supporting both product innovation and regulatory compliance across global dairy supply chains.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $1.9 Billion |
| Forecast Value | $4.7 Billion |
| CAGR | 9.4% |
The ultrafiltration segment generated USD 909 million in 2025, accounting for 47.5% share, and is projected to reach USD 2.30 billion by 2035 at a CAGR of 9.8%. This segment remains central to dairy processing operations, with membrane systems widely used for whey protein concentration, milk protein concentrate production, and pre-concentration processes in large-scale dairy facilities across key producing regions.
The whey processing segment reached USD 608 million, holding 31.7% share, and is expected to grow at a CAGR of 9.1% to reach USD 1.45 billion by 2035. This dominance is driven by the essential role of membrane filtration in whey protein production systems, where ultrafiltration enables the economic production of high-value protein concentrates and isolates at an industrial scale, supporting global demand for protein-rich dairy ingredients.
North America Ultra-Filtration and Microfiltration in Dairy Processing Market accounted for USD 566 million in 2025. The United States remains the primary demand hub, supported by a highly developed whey processing industry and extensive membrane filtration infrastructure concentrated in major dairy-producing regions. Strong integration of advanced separation technologies within large-scale dairy processing facilities continues to reinforce regional market leadership.
Major players operating in the global ultra-filtration & microfiltration in dairy processing industry are Dexcom, Inc., Medtronic Plc, Abbott Laboratories, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Tandem Diabetes Care, Inc., Insulet Corporation, Ypsomed Holding, Ascensia Diabetes Care Holdings AG, DarioHealth Corporation, Senseonics, Glooko Inc., Emperra GmbH E-Health Technologies, Pendiq. Companies operating in the ultra-filtration and microfiltration in dairy processing market are focusing on expanding membrane efficiency and improving separation performance through advanced material engineering and optimized pore structure designs. Many players are investing in automation and digital monitoring systems to enhance process control, reduce downtime, and improve yield consistency across dairy production lines. Strategic collaborations with dairy processors are strengthening long-term supply contracts and enabling customized system integration for whey and milk processing applications. Firms are also prioritizing energy-efficient membrane technologies to reduce operational costs and improve sustainability performance in large-scale plants.